On the 13th of November, 2021, Sri Sankaradeva Nethralaya launched the "Innovation Club" of SSDN, which was inaugurated by the Chief Guest of the evening; Mrs.Riniki Bhuyan Sarma, Managing Director of Pride East Entertainment Pvt. Ltd. Mrs. Sarma is an eminent social figure of Assam who has contributed to innumerable social causes for the upliftment and betterment of the society over the years. On the occasion Mrs. Sarma lauded the institution for working relentlessly for its dedicated service to the people of the Northeast.
Alongside its primary Community Service and Clinical responsibilities, Sri Sankaradeva Nethralaya has also emerged as one of the finest research institutions in the North East. Since the time of its inception, Sri Sankaradeva Nethralaya has been part of several research projects pertaining to the field of Ophthalmology, at both national as well as international level. Over the years SSDN has partnered and collaborated with various notable institutions in several such projects and clinical trials for research In pursuit of advancement in the field of ophthalmology. In recent years, a team of researchers at IIT Guwahati and Shri Sankaradeva Nethralaya Guwahati developed and patented a testing device to detect diabetic retinopathy at an early stage without the need for invasive testing. The research was funded by the Ministry of Human Resource and Development, Indian Council of Medical Research and Ministry of Electronics and Information Technology.
To honor its good work and contributions in the field of research Sri Sankaradeva Nethralaya formally launched its Research Wing on the 13th of October, 2021. Aptly titled, the ‘Innovation Club’, the club announced its agenda and goals for the years ahead –
Execution of targeted tasks for the purpose of innovation in a phased manner. Periodic auditing of the progress of the club. Discussions with external faculties of other reputed national and institutions like IIT, Guwahati; various major industrial players etc. for product innovation. Organizing innovative meetings, product discussions and creative teachings as part of an Intellectual interaction.
The newly formed Innovation Club initially constitutes of several noted members of the Sri Sankaradeva Nethralaya family. The constituent members of the Innovation Club are –
1. Dr. Dipankar Das (MBBS, MS), Sr. Consultant and HOD - Uveitis – Ocular Pathology 2. Dr. Nilutparna Deuri (MBBS, DO, DNB), Consultant 3. Mr. Tridip Pujari (M.Sc. & M.Sc. OA); Faculty, School of Optometry 4. Mr. Surabhi Suman Kalita (M.Optom); Faculty, School of Optometry 5. Mr. Jico Gogoi (M. Opt Anaplastology; Associate Member Ocularist Society of India); Ocularist & Anaplastologist 6. Mr. Apurba Deka; (M.Sc.); Lab Tech cum Quality Manager - Ocular Pathology Lab
Ophthalmic Pathology: Innovation/ discoveries/first to describe
1. Coined “Efferocytosis in retinoblastoma” for unique apoptotic change in cancer (Retinoblastoma) biology [Published- 2013]
2. Described a new rosette (Das) in retinoblastoma [Published- 2014]
3. Described and documented “ Endothelial podosome rosette formed by endothelial cells in human cavernous hemangioma” [Published- 2016]
4. Described for the first time rapid direct pathological diagnosis of live worms under the objective of compound microscope in the laboratory and developed a innovative algorithm for “ live parasite examination” [Published in 2016]
5. Described first- Intraocular IgG4 related disease masquerading as ciliary body melanoma in a young girl [Published in 2016]
6. Found newly discovered rosette (Das Rosette) was associated with poor prognosis of retinoblastoma : Molecular pathologic evidence [Published- 2017]
7. Found optic nerve as “ Human Biometric Signature” [Published- 2017]
8. Found evidence of zonular stress lines on human crystalline lens-Pathological study [Published 2018]
9. CD 68 (Dendritic cell, IHC) expression in retinal ganglion cells, peripapillary optic nerve and trabecular meshwork for future drug delivery concept in glaucoma (Extended work planned-multi centre-SSN/NIPER: “Design of targeted topical nanoformulation with the help of efficient artificial intelligence and machine learning algorithms to find a common drug-cellular linkage supported by a molecular marker CD68 for preventing the optic nerve damage in glaucomatous eyes) [ Sent for publication to IJP]
10. First reported transposition of great arteries (TGA) associated with bilateral anterior uveitis [Published in 2019]
11. Patent Publication: Point-of-Care-Testing Devices for Diverse Diseases from Human Tear Biomarkers (Co- Inventor)-Patent published: Page no. 35395 of the Office Journal of the Patent Office (Controller General of Patents, Design and Trademarks, Govt.of India), Journal no 32/2019 Dated : 09/08/2019. [Application No. 201931028121A)/ Published in American Chemical Society Journal on 3.6.2020]
12. Co-author of paper/Innovation: Bio-nanocomposite Assembly: A potent onsite Bio-larvicidal Agent against Mosquito Disease Vector. Published in Royal Society of Chemistry Adv., 2020, 10, 9356 DOI: 10.1039/c9ra09972g ( Colaborative work with Defence Research Laboratory- Tezpur (DRDO-New Delhi); in DBT funded project; VSC-Khanapara, Guwahati, INDIA) [Published in 2020]
13. Innovated: Sodium fluorescein (C20H12O5NA) as a novel dye for raw tissue staining in ophthalmic pathology/microbiology [Published in IJO on 23.9.2020]
14. Rare case report- Nevus of Ota with Palatal Involvement and Helicobacter pylori Gastritis [Published in IJO-Case Rep. on 31.12.2020]
15. Pathologic evidence of retinoblastoma seeds supported by field emission scanning electron microscopy and Raman Spectroscopy [Will be published in IJO Dec 2021]
16. Retinblastoma and post chemo- retinal pigment epithelium (RPE) chang [Unpublished]
17. FESEM study in orbital venous malformation (previously called cavernous hemangioma) [Published in IJO CRs on 9.10.2021] and chroidal melanoma seeds [Unpublished Case]
18. Molluscum contagiosum as seen by fluorescein stain. Will be published in IJO-CR in Jan-2022
Powered By GenX
